Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Total Non-Current Liabilities came in at $334.2 million in Q1 2026, up 13.97% year-on-year from $293.2 million in Q1 2025, and up 0.5% quarter-over-quarter from $332.5 million in Q4 2025.

Establishment Labs Holdings (ESTA) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $334.2 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 13.97% year-over-year to $334.2 million in Q1 2026; TTM through Mar 2026 was $334.2 million, a 13.97% increase from a year earlier, with the FY2025 full-year figure at $332.5 million, up 13.84% from the prior year.
  • Total Non-Current Liabilities climbed to $334.2 million in Q1 2026 per ESTA's latest filing, from $332.5 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $334.2 million in Q1 2026 and bottomed at $91.9 million in Q1 2022.
  • The 5-year median for Total Non-Current Liabilities is $243.4 million (2024), against an average of $248.7 million.
  • Across the five-year window, Total Non-Current Liabilities surged 151.88% in 2022 and grew 4.25% in 2024, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $217.6 million in 2022, then advanced by 14.24% to $248.6 million in 2023, then gained by 17.48% to $292.1 million in 2024, then gained by 13.84% to $332.5 million in 2025, then rose by 0.5% to $334.2 million in 2026.
  • Per Business Quant, the three latest ESTA Total Non-Current Liabilities figures stand at $334.2 million (Q1 2026), $332.5 million (Q4 2025), and $321.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Establishment Labs Holdings 2.73 Bn 2.66 Bn 42.34 Mn 334.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 334.15 Mn
Dec 31, 2025 332.48 Mn
Sep 30, 2025 321.42 Mn
Jun 30, 2025 305.24 Mn
Mar 31, 2025 293.18 Mn
Dec 31, 2024 292.06 Mn
Sep 30, 2024 248.68 Mn
Jun 30, 2024 238.61 Mn
Mar 31, 2024 243.38 Mn
Dec 31, 2023 248.60 Mn
Sep 30, 2023 238.54 Mn
Jun 30, 2023 228.43 Mn
Mar 31, 2023 223.53 Mn
Dec 31, 2022 217.62 Mn
Sep 30, 2022 186.13 Mn
Jun 30, 2022 184.02 Mn
Mar 31, 2022 91.90 Mn
Dec 31, 2021 86.40 Mn
Sep 30, 2021 84.65 Mn
Jun 30, 2021 81.07 Mn